Smith & Nephew (SNNUF) Asset Utilization Ratio (2009 - 2024)

Smith & Nephew (SNNUF) reported Asset Utilization Ratio of 0.96 for Q4 2024, down 99.86% quarter-over-quarter from 694.21 in Q4 2022.

Smith & Nephew (SNNUF) Asset Utilization Ratio (2009 - 2024) Analysis & Trends

Smith & Nephew has reported Asset Utilization Ratio for 13 years, with the latest figure at 0.96 in Q4 2024.

For the quarter ending Q4 2024, Asset Utilization Ratio changed N/A year-over-year to 0.96; the trailing twelve-month figure through Dec 2024 stood at 0.96 (changed N/A YoY), and the FY2025 full-year result was 0.59, down 47.18% from the prior year.
Asset Utilization Ratio for Q4 2024 stood at 0.96, down from 694.21 in the prior quarter.
The five-year high for Asset Utilization Ratio was 1006.21 in Q4 2021, with the low at 0.96 in Q4 2024.
Historically, Asset Utilization Ratio has averaged 425.83 across 4 years, with a median of 348.08 in 2020.
Annual changes were most pronounced in 2021 — Asset Utilization Ratio soared 51574.37% — and 2022, when it plunged 31.01%.
Smith & Nephew's Asset Utilization Ratio stood at 1.95 in 2020, then soared by 51574.37% to 1006.21 in 2021, then plunged by 31.01% to 694.21 in 2022, then slumped by 99.86% to 0.96 in 2024.
The last three Asset Utilization Ratio figures came in at 0.96 (Q4 2024), 694.21 (Q4 2022), and 1006.21 (Q4 2021), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	0.46
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	0.54
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	0.39
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	0.47
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	0.47
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	0.57
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.65
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	0.74
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	0.56
10	Smith & Nephew	-	-	-	-

Download Data